BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4068201)

  • 1. Plasma noradrenaline and its deaminated metabolites in essential hypertension and pheochromocytoma.
    Mizukoshi M; Hano T; Kuchii M; Nishio I; Masuyama Y
    Jpn Circ J; 1985 Sep; 49(9):1035-42. PubMed ID: 4068201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of free and total catecholamines and two deaminated metabolites in man--rapid deconjugation by heat in acid.
    Vlachakis ND; Kogosov E; Yoneda S; Alexander N; Maronde RF
    Clin Chim Acta; 1984 Feb; 137(2):199-209. PubMed ID: 6705233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of phaeochromocytoma in patients with borderline elevation of plasma noradrenaline concentration.
    Brown MJ
    Eur J Clin Invest; 1984 Feb; 14(1):67-72. PubMed ID: 6421600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatographic method for the determination of 3,4-dihydroxyphenylethylene glycol and 3,4-dihydroxymandelic acid in plasma.
    Eriksson BM; Persson BA
    J Chromatogr; 1987 Jan; 386():1-9. PubMed ID: 3104378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of endogenous and exogenous noradrenaline in the rabbit perfused heart.
    Majewski H; Hedler L; Steppeler A; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):125-9. PubMed ID: 7110374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioenzymatic assay for plasma dihydroxyphenylglycol (DHPG), dihydroxymandelic acid (DOMA) and dihydroxyphenylacetic acid (DOPAC).
    Izzo JL; Greulich D
    Life Sci; 1983 Aug; 33(5):483-8. PubMed ID: 6877032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 3-methoxy-4-hydroxyphenethyleneglycol in pheochromocytoma.
    Lehnert H; Walger P
    Cardiology; 1985; 72 Suppl 1():160-2. PubMed ID: 4053125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 3,4-dihydroxyphenylglycol as a tool to assess the role of neuronal uptake in the anaesthetized rabbit.
    Halbrügge T; Wölfel R; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):726-32. PubMed ID: 2634246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of noradrenaline and 3,4-dihydroxyphenylethyleneglycol under conditions of enhanced sympathetic activity.
    Ludwig J; Gerhardt T; Halbrügge T; Walter J; Graefe KH
    Eur J Clin Pharmacol; 1988; 35(3):261-7. PubMed ID: 3181279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.
    Halbrügge T; Gerhardt T; Ludwig J; Heidbreder E; Graefe KH
    Life Sci; 1988; 43(1):19-26. PubMed ID: 3386411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of plasma 3,4-dihydroxyphenylglycol (DOPEG) in analyses of the sympathetic nervous system in vivo.
    Graefe KH; Halbrügge T; Gerlich M; Ludwig J
    J Neural Transm Suppl; 1990; 32():421-9. PubMed ID: 2089106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of endogenous and exogenous noradrenaline in guinea-pig atria.
    Starke K; Hedler L; Steppeler A
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):193-8. PubMed ID: 7322211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of noradrenaline metabolism in depressed patients by the determination of plasma dihydroxyphenylethylene glycol].
    Lôo H; Scatton B; Dennis T; Benkelfat C; Gay C; Poirier-Littré MF; Garreau M; Vanelle JM; Olié JP; Deniker P
    Encephale; 1983; 9(4):297-316. PubMed ID: 6671452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.
    Branco D; Caramona M; Martel F; de Almeida JA; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects on presynaptic noradrenaline metabolism.
    Ludwig J; Halbrügge T; Graefe KH
    J Neural Transm Suppl; 1991; 34():69-75. PubMed ID: 1817166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries.
    Figueiredo IV; Caramona M; Paiva MQ; Guimarães S
    J Auton Pharmacol; 1998 Apr; 18(2):123-8. PubMed ID: 9730267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of 3H-(--)noradrenaline in the perfused cat and rabbit heart.
    Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):71-82. PubMed ID: 7329455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroxyphenylglycol and dihydroxymandelic acid during intravenous infusions of noradrenaline.
    Eisenhofer G; Goldstein DS; Stull R; Ropchak TG; Keiser HR; Kopin IJ
    Clin Sci (Lond); 1987 Jul; 73(1):123-5. PubMed ID: 3608373
    [No Abstract]   [Full Text] [Related]  

  • 19. A sensitive radioenzymatic assay for dihydroxymandelic acid, dihydroxypenylglycol and dihydroxyphenylacetic acid .
    Nagel-Hiemke M; Schümann HJ
    J Biochem Biophys Methods; 1981 Jun; 4(5-6):261-70. PubMed ID: 7019296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol].
    Loo H; Scatton B; Poirier MF; Benkelfat C; Dennis T; Vanelle JM; Garreau M; Sechter D
    Presse Med; 1985 Jun; 14(25):1363-6. PubMed ID: 3161030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.